Hudson Bay Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Hudson Bay Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,447	Closed	-$5.18M	–	1498
2025 Q4	$5.18M	Buy	+30,447	New	+$4.67M	0.02%	493
2025 Q3	–	Sell	-27,083	Closed	-$2.87M	–	1453
2025 Q2	$2.87M	Buy	+27,083	New	+$2.94M	0.01%	697
2024 Q2	–	Sell	-50,000	Closed	-$6.02M	–	861
2024 Q1	$6.02M	Buy	50,000 +37,400	+297%	+$4.58M	0.03%	263
2023 Q4	$1.55M	Sell	12,600 -25,133	-67%	-$3.14M	0.01%	481
2023 Q3	$4.88M	Buy	+37,733	New	+$5.03M	0.04%	293
2021 Q4	–	Sell	-17,500	Closed	-$2.28M	–	1141
2021 Q3	$2.28M	Buy	+17,500	New	+$2.64M	0.03%	600

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Hudson Bay Capital Management's JAZZ Position: Q1 2026 in Review

Hudson Bay Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 30,447 shares — an estimated $5.18M sold.

Hudson Bay Capital Management first reported a position in JAZZ in Q3 2021 and held it in 6 quarters. The position peaked at $6.02M in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Hudson Bay Capital Management reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Hudson Bay Capital Management sold 30,447 Jazz Pharmaceuticals shares in Q1 2026, an estimated $5.18M.
Hudson Bay Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2021 and held it in 6 quarters.
Hudson Bay Capital Management's Jazz Pharmaceuticals position peaked at $6.02M in Q1 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.